《中国中医药信息杂志》[ISSN:1005-5304/CN:11-3519/R]
Volume:
27卷
Issue:
2020年12期
Page:
120-122
Research Field:
经验交流
Publishing date:
2020-12-01
- Title:
-
Experience of Gao Ronglin in Using Huanghong Shengmai Powder for Treatment of Coronary Atherosclerotic Heart Disease
- Author(s):
-
DAI Fangyuan; LI Ping
-
Third Affiliated Hospital of Beijing University of Chinese Medicine, Beijing 100029, China
-
- Keywords:
-
experience of famous doctors; Gao Ronglin; Huanghong Shengmai Powder; coronary atherosclerotic heart disease
- PACS:
-
R259.414
- DOI:
-
10.19879/j.cnki.1005-5304.201902057
- Abstract:
-
Professor G ao Ronglin has been engaged in the clinical work of difficult and complicated diseases for nearly 60 years. He has unique insights in the treatment of coronary atherosclerotic heart disease (CHD) . He believes that the pathogenesis of CHD is based on positive qi deficiency (inhibition of qi and yin), and the plaque which includes phlegm and blood stasis is the manifestation. He advocates the classic doctrine of "positive qi inside body, pathogens cannot invade", combines TCM pharmacy and modern pharmacology closely, and creates Huanghong Shengmai Powder (Astragali Radix, Rhodiolae Crenulatae Radix et Rhizoma , Codonipsis Radix / Panacis Quinguefolii Radix, Ophiopogonis Radix, and Schisandra Chinensis Fructus) to treat CHD . On the basis of disease differentiation, syndrome differentiation and treatment, he believes "viewing its pulse syndrome, knowing what mistaken therapy was applied, taking targeted treatments". ①phlegm-heat syndrome: to combine modified Erchen Decoction with Xiaoxianxiong Decoction and so on; ②blood stasis syndrome: to combine modified Danshen Decoction with Notoginseng Radix et Rhizoma and so on; ③qi stagnation with chest pain : to combine Curcumae Radix, etc.; ④chest-yang dysfunction: to combine Gualou Xiebai Decoction , etc.; ⑤with rapid arrhythmia: to add Sophorae Flavescentis Radix, Nardostachyos Radix et Rhizoma, and so on; ⑥liver-heat syndrome: to add antelope horn Powder, etc. In a word, Huanghong Shengmai Powder is the basis in clinical application, and it can be flexibly a dded and subtracted according to the syndrome, time, place and people, with good efficacy.
References:
[1] 葛均波,徐永健.内科学[M].8版.北京：人民卫生出版社,2013：154.
[2] 周欢,张军平,王彬.冠状动脉粥样硬化性心脏病之“狭窄”“斑块”说拨误[J].心脏杂志,2018,30(1)：107-112.
[3] 刘红,艾明仙,阳辉.生脉散对自由基致大鼠离体心脏损伤保护作用[J].中国公共卫生,2007,23(7)：847-849.
[4] 赵娜.大株红景天化学成分及抗氧化活性研究[D].天津：天津医科大学,2016.